Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
News Medical on MSN
Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received
Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...
With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Reflecting on his diagnosis, Charlie Sheen questions why a medication he once used never became widely available.
HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...
The tools to stop the spread of HIV are readily available, but experts said they're not getting to the right people.
LGBTQ Nation on MSN
Groundbreaking HIV-prevention med won’t harm trans people’s hormone therapy
Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...
7d
Charlie Sheen claims experimental HIV drug was kept off market because 'it's a threat' to industry
Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 ...
Bianca Carolina, an HIV advocate, shares her story to end the stigma associated with HIV, showing that life, love, and family are still possible after diagnosis.
Sheen appeared on the “Today” show in 2015 and revealed his HIV status, saying doctors had detected the virus four years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback